Research output: Contribution to journal › Article › peer-review
Biological safety and biodistribution of chitosan nanoparticles. / Sonin, Dmitry; Pochkaeva, Evgeniia; Zhuravskii, Sergei; Postnov, Viktor; Korolev, Dmitry; Vasina, Lyubov; Kostina, Daria; Mukhametdinova, Daria; Zelinskaya, Irina; Skorik, Yury; Naumysheva, Elena; Malashicheva, Anna; Somov, Pavel; Istomina, Maria; Rubanova, Natalia; Aleksandrov, Ilia; Vasyutina, Marina; Galagudza, Michael.
In: Nanomaterials, Vol. 10, No. 4, 810, 04.2020.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Biological safety and biodistribution of chitosan nanoparticles
AU - Sonin, Dmitry
AU - Pochkaeva, Evgeniia
AU - Zhuravskii, Sergei
AU - Postnov, Viktor
AU - Korolev, Dmitry
AU - Vasina, Lyubov
AU - Kostina, Daria
AU - Mukhametdinova, Daria
AU - Zelinskaya, Irina
AU - Skorik, Yury
AU - Naumysheva, Elena
AU - Malashicheva, Anna
AU - Somov, Pavel
AU - Istomina, Maria
AU - Rubanova, Natalia
AU - Aleksandrov, Ilia
AU - Vasyutina, Marina
AU - Galagudza, Michael
PY - 2020/4
Y1 - 2020/4
N2 - The effect of unmodified chitosan nanoparticles with a size of similar to 100 nm and a weakly positive charge on blood coagulation, metabolic activity of cultured cardiomyocytes, general toxicity, biodistribution, and reactive changes in rat organs in response to their single intravenous administration at doses of 1, 2, and 4 mg/kg was studied. Chitosan nanoparticles (CNPs) have a small cytotoxic effect and have a weak antiplatelet and anticoagulant effect. Intravenous administration of CNPs does not cause significant hemodynamic changes, and 30 min after the CNPs administration, they mainly accumulate in the liver and lungs, without causing hemolysis and leukocytosis. The toxicity of chitosan nanoparticles was manifested in a dose-dependent short-term delay in weight gain with subsequent recovery, while in the 2-week observation period no signs of pain and distress were observed in rats. Granulomas found in the lungs and liver indicate slow biodegradation of chitosan nanoparticles. In general, the obtained results indicate a good tolerance of intravenous administration of an unmodified chitosan suspension in the studied dose range.
AB - The effect of unmodified chitosan nanoparticles with a size of similar to 100 nm and a weakly positive charge on blood coagulation, metabolic activity of cultured cardiomyocytes, general toxicity, biodistribution, and reactive changes in rat organs in response to their single intravenous administration at doses of 1, 2, and 4 mg/kg was studied. Chitosan nanoparticles (CNPs) have a small cytotoxic effect and have a weak antiplatelet and anticoagulant effect. Intravenous administration of CNPs does not cause significant hemodynamic changes, and 30 min after the CNPs administration, they mainly accumulate in the liver and lungs, without causing hemolysis and leukocytosis. The toxicity of chitosan nanoparticles was manifested in a dose-dependent short-term delay in weight gain with subsequent recovery, while in the 2-week observation period no signs of pain and distress were observed in rats. Granulomas found in the lungs and liver indicate slow biodegradation of chitosan nanoparticles. In general, the obtained results indicate a good tolerance of intravenous administration of an unmodified chitosan suspension in the studied dose range.
KW - Biodistribution
KW - Blood compatibility
KW - Chitosan
KW - In vivo treatment
KW - Polymer nanoparticles
KW - Safety evaluation
KW - chitosan
KW - INDOCYANINE GREEN
KW - BIOCOMPATIBILITY
KW - polymer nanoparticles
KW - biodistribution
KW - MICELLES
KW - blood compatibility
KW - in vivo treatment
KW - DELIVERY-SYSTEM
KW - IN-VITRO
KW - safety evaluation
KW - PHARMACOKINETICS
KW - N-SUCCINYL-CHITOSAN
KW - LOADED NANOPARTICLES
KW - DERIVATIVES
KW - AGGREGATION
UR - http://www.scopus.com/inward/record.url?scp=85083863714&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/12879a27-12c9-318b-bda5-4b514c0a39fc/
U2 - 10.3390/nano10040810
DO - 10.3390/nano10040810
M3 - Article
AN - SCOPUS:85083863714
VL - 10
JO - Nanomaterials
JF - Nanomaterials
SN - 2079-4991
IS - 4
M1 - 810
ER -
ID: 53236845